Pharmaceutical formulations
US4997651A · kind A · utility
19Cited by
4References
16Claims
0Family size
Inventors
Key dates
| Filing date | Nov 18, 1988 |
| Grant date | Mar 5, 1991 |
| Priority date | — |
| Expiry date | Nov 18, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a new two-component pharmaceutical formulation of melphalan in which the two components comprise PA0 (a) freeze-dried mephalan hydrochloride and PA0 (b) a solvent-diluent comprising a citrate, propylene glycol and ethanol. Substantially pure melphalan, substantially pure melphalan hydrochloride and methods for preparing them are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.